.
.
Ključne reči:
.
Sažetak
.
Reference
[1] Jung K, Kang H, Mehra R. Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC). Cancers Head Neck. 2018 Jun 4;3:3. doi: 10.1186/s41199-018-0030-z. PMID: 31093356; PMCID: PMC6460806.
[2] Lakshminarayana S, Augustine D, Rao RS, et al. Molecular pathways of oral cancer that predict prognosis and survival: A systematic review. J Carcinog. 2018 Dec 31;17:7. doi: 10.4103/jcar.JCar_17_18. PMID: 30766450; PMCID: PMC6334533.
[3] Cai Y, Dodhia S, Su GH. Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma. Oncotarget. 2017 Mar 28;8(13):22203-22217. doi: 10.18632/oncotarget.14729. PMID: 28108737; PMCID: PMC5400658.
[4] Szturz P, Vermorken JB. Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher. Oral Oncol. 2020 Feb;101:104492. doi: 10.1016/j.oraloncology.2019.104492. Epub 2019 Dec 11. PMID: 31837576.
[5] Lamb MC, Tootle TL. Fascin in Cell Migration: More Than an Actin Bundling Protein. Biology (Basel). 2020 Nov 17;9(11):403. doi: 10.3390/biology9110403. PMID: 33212856; PMCID: PMC7698196.
[6] Liu H, Zhang Y, Li L,et al. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Mol Ther Oncolytics. 2021 Jan 20;20:240-264. doi: 10.1016/j.omto.2020.12.014. PMID: 33614909; PMCID: PMC7873579.
[7] Pfisterer K, Jayo A, Parsons M. Control of nuclear organization by F-actin binding proteins. Nucleus. 2017 Mar 4;8(2):126-133. doi: 10.1080/19491034.2016.1267093.
[8] Almangush A, Heikkinen I, Mäkitie AA, et al. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer. 2017 Sep 5;117(6):856-866. doi: 10.1038/bjc.2017.244. Epub 2017 Jul 27. PMID: 28751758; PMCID: PMC5589992.
[9] Kiyohara T, Miyamoto M, Shijimaya T,et al. Pseudovascular squamous cell carcinoma: A review of the published work and reassessment of prognosis. J Dermatol. 2018 Dec;45(12):1448-1451. doi: 10.1111/1346-8138.14640. Epub 2018 Sep 11. PMID: 30204258.
[10] Liu L, Xue X, Xue L. Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review. Diagn Pathol. 2019 Sep 6;14(1):102. doi: 10.1186/s13000-019-0881-6. PMID: 31488173; PMCID: PMC6729002.
[11] Liu L, Xue X, Xue L. Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review. Diagn Pathol. 2019 Sep 6;14(1):102. doi: 10.1186/s13000-019-0881-6. PMID: 31488173; PMCID: PMC6729002.
[12] Qiu X, Meng Y, Lu M, et al. Primary squamous cell carcinoma of the pancreas with a large pseudocyst of the pancreas as the first manifestation: a rare case report and literature review. BMC Gastroenterol. 2021 May 8;21(1):208. doi: 10.1186/s12876-021-01804-7. PMID: 33964875; PMCID: PMC8105924.
[13] Roslan NH, Makpol S, Mohd Yusof YA. A Review on Dietary Intervention in Obesity Associated Colon Cancer. Asian Pac J Cancer Prev. 2019 May 25;20(5):1309-1319. doi: 10.31557/APJCP.2019.20.5.1309. PMID: 31127882; PMCID: PMC6857900.
[14] Pirozzi F, Ren K, Murabito A, et al. PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy. Curr Med Chem. 2019;26(16):2791-2800. doi: 10.2174/0929867325666180320120054. PMID: 29557740.
[15] Ijaz S, Akhtar N, Khan MS, et al. Plant derived anticancer agents: A green approach towards skin cancers. Biomed Pharmacother. 2018 Jul;103:1643-1651. doi: 10.1016/j.biopha.2018.04.113. Epub 2018 May 7. PMID: 29864953.
[16] Zhou Y, Hu W, Chen P, et al. Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Aug;96(34):e7911. doi: 10.1097/MD.0000000000007911. PMID: 28834915; PMCID: PMC5572037.
[17] Kiupel M, Camus M. Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):819-836. doi: 10.1016/j.cvsm.2019.04.002. Epub 2019 Jun 6. PMID: 31178200.
[18] Elmaci İ, Altinoz MA, Bolukbasi FH, et al. Paradoxical results obtained with Ki67-labeling and PHH3-mitosis index in glial tumors: a literature analysis. Clin Neuropathol. 2017 Nov/Dec;36(6):272-282. doi: 10.5414/NP301028. PMID: 28853695.
[19] Miettinen MM, Antonescu CR, Fletcher CDM, et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol. 2017 Sep;67:1-10. doi: 10.1016/j.humpath.2017.05.010. Epub 2017 May 24. PMID: 28551330; PMCID: PMC5628119.
[20] Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018 Dec;31(12):1770-1786. doi: 10.1038/s41379-018-0110-y. Epub 2018 Aug 23. PMID: 30140036; PMCID: PMC6265262.
[2] Lakshminarayana S, Augustine D, Rao RS, et al. Molecular pathways of oral cancer that predict prognosis and survival: A systematic review. J Carcinog. 2018 Dec 31;17:7. doi: 10.4103/jcar.JCar_17_18. PMID: 30766450; PMCID: PMC6334533.
[3] Cai Y, Dodhia S, Su GH. Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma. Oncotarget. 2017 Mar 28;8(13):22203-22217. doi: 10.18632/oncotarget.14729. PMID: 28108737; PMCID: PMC5400658.
[4] Szturz P, Vermorken JB. Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher. Oral Oncol. 2020 Feb;101:104492. doi: 10.1016/j.oraloncology.2019.104492. Epub 2019 Dec 11. PMID: 31837576.
[5] Lamb MC, Tootle TL. Fascin in Cell Migration: More Than an Actin Bundling Protein. Biology (Basel). 2020 Nov 17;9(11):403. doi: 10.3390/biology9110403. PMID: 33212856; PMCID: PMC7698196.
[6] Liu H, Zhang Y, Li L,et al. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Mol Ther Oncolytics. 2021 Jan 20;20:240-264. doi: 10.1016/j.omto.2020.12.014. PMID: 33614909; PMCID: PMC7873579.
[7] Pfisterer K, Jayo A, Parsons M. Control of nuclear organization by F-actin binding proteins. Nucleus. 2017 Mar 4;8(2):126-133. doi: 10.1080/19491034.2016.1267093.
[8] Almangush A, Heikkinen I, Mäkitie AA, et al. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer. 2017 Sep 5;117(6):856-866. doi: 10.1038/bjc.2017.244. Epub 2017 Jul 27. PMID: 28751758; PMCID: PMC5589992.
[9] Kiyohara T, Miyamoto M, Shijimaya T,et al. Pseudovascular squamous cell carcinoma: A review of the published work and reassessment of prognosis. J Dermatol. 2018 Dec;45(12):1448-1451. doi: 10.1111/1346-8138.14640. Epub 2018 Sep 11. PMID: 30204258.
[10] Liu L, Xue X, Xue L. Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review. Diagn Pathol. 2019 Sep 6;14(1):102. doi: 10.1186/s13000-019-0881-6. PMID: 31488173; PMCID: PMC6729002.
[11] Liu L, Xue X, Xue L. Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review. Diagn Pathol. 2019 Sep 6;14(1):102. doi: 10.1186/s13000-019-0881-6. PMID: 31488173; PMCID: PMC6729002.
[12] Qiu X, Meng Y, Lu M, et al. Primary squamous cell carcinoma of the pancreas with a large pseudocyst of the pancreas as the first manifestation: a rare case report and literature review. BMC Gastroenterol. 2021 May 8;21(1):208. doi: 10.1186/s12876-021-01804-7. PMID: 33964875; PMCID: PMC8105924.
[13] Roslan NH, Makpol S, Mohd Yusof YA. A Review on Dietary Intervention in Obesity Associated Colon Cancer. Asian Pac J Cancer Prev. 2019 May 25;20(5):1309-1319. doi: 10.31557/APJCP.2019.20.5.1309. PMID: 31127882; PMCID: PMC6857900.
[14] Pirozzi F, Ren K, Murabito A, et al. PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy. Curr Med Chem. 2019;26(16):2791-2800. doi: 10.2174/0929867325666180320120054. PMID: 29557740.
[15] Ijaz S, Akhtar N, Khan MS, et al. Plant derived anticancer agents: A green approach towards skin cancers. Biomed Pharmacother. 2018 Jul;103:1643-1651. doi: 10.1016/j.biopha.2018.04.113. Epub 2018 May 7. PMID: 29864953.
[16] Zhou Y, Hu W, Chen P, et al. Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Aug;96(34):e7911. doi: 10.1097/MD.0000000000007911. PMID: 28834915; PMCID: PMC5572037.
[17] Kiupel M, Camus M. Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):819-836. doi: 10.1016/j.cvsm.2019.04.002. Epub 2019 Jun 6. PMID: 31178200.
[18] Elmaci İ, Altinoz MA, Bolukbasi FH, et al. Paradoxical results obtained with Ki67-labeling and PHH3-mitosis index in glial tumors: a literature analysis. Clin Neuropathol. 2017 Nov/Dec;36(6):272-282. doi: 10.5414/NP301028. PMID: 28853695.
[19] Miettinen MM, Antonescu CR, Fletcher CDM, et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol. 2017 Sep;67:1-10. doi: 10.1016/j.humpath.2017.05.010. Epub 2017 May 24. PMID: 28551330; PMCID: PMC5628119.
[20] Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018 Dec;31(12):1770-1786. doi: 10.1038/s41379-018-0110-y. Epub 2018 Aug 23. PMID: 30140036; PMCID: PMC6265262.
Objavljeno
2025/05/24
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Jianming Wei
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.